Disclosures for "Clinical Response of Recurrent Ganglioglioma with BRAF A598_T599insV Mutation to BRAF/MEK Inhibitors"
-
Mr. Reynoso has nothing to disclose.
-
Dr. Chen has nothing to disclose.
-
Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.